The National Blood Clot Alliance (NBCA), a leading patient advocacy group focused on the prevention, early diagnosis, and treatment of venous blood clots, has endorsed DEFIANCE, a multinational, prospective randomised controlled trial

GE HealthCare will lead the Synthia consortium project, which aims to evaluate methods for generating synthetic data. This initiative will focus on creating synthetic datasets and using them to develop artificial intelligence (AI) algorithms.

Advanced Care Group,?a leading healthcare recruitment firm, has announced its expansion into the United Arab Emirates and Saudi Arabia, with new headquarters in Dubai and a regional office in Riyadh.

Vivos Therapeutics, a medical technology company focused on developing treatments for sleep-related breathing disorders such as obstructive sleep apnea (OSA), has announced the introduction

LENSAR, a global medical technology company specialising in advanced robotic laser solutions for cataract treatment, has announced that its technology has been used in over one million procedures. This milestone reflects

PsychoGenics Inc. has secured a contract from the National Institutes of Health (NIH) to explore and identify new investigational therapies for pain management.

HoneyNaps announced on 9 September that it has commenced exports of its artificial intelligence sleep disorder diagnostic software, SOMNUM, to two medical institutions in the United States.

Researchers announced significant findings from a pilot study conducted in partnership with Precision Neuroscience Corporation at the Society for Neuroscience (SfN) Neuroscience

At the Neuroscience 2024 conference, Bruker Corporation (Nasdaq: BRKR) unveiled the OptoVolt? module, designed to enhance neuroscience research capabilities on the Ultima multiphoton microscope platform.

OrthAlign, a private medical device company, has secured FDA 510(k) clearance for its Lantern Hip handheld technology, specifically designed for direct anterior total hip arthroplasty